Skip to main content
 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 10, 2025
Expenses
$150,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Virginia

Official filing document

 Lobbying activity 1

Medicare reimbursement and incident-to billing, Medicare hospice restrictions, telehealth, transparency, healthcare competition, coverage and access to mental health and primary care services, PA inclusion in the federal workers compensation program, the Promoting Access to Diabetic Shoes Act (HR 1616), the Increasing Access to Quality Cardiac Rehabilitation Care Act (S. 717), claims-based enrollment in ACOs, the Improving Care and Access to Nurses Act (S. 575, HR 1317), States Handling Access to Reciprocity for Employment Act (HR 1310), the Create More Behavioral Health Providers Act (S. 683), The CONNECT for Health Act, extending Medicare telehealth policies, (S. 1261).

 Bills named in this filing 7
  • H.R. 1616
    Promoting Access to Diabetic Shoes Act
  • S. 717
    Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025
  • S. 575
    I CAN Act
  • H.R. 1317
    I CAN Act
  • H.R. 1310
    POSTAL Act
  • S. 683
    More Behavioral Health Providers Act of 2025
  • S. 1261
    CONNECT for Health Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem